Skip to main content

Canagliflozin (Amorphous)

Therapy Area
Anti-Diabetic
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Available
Available Regulatory Filing
USA
Tunisia
Europe
Innovator Brand (US)
INVOKANA

We are here to help, if you have any country specific requirements - please Contact Us.